Learn about Central Retinal Vein Occlusion (CRVO), a retinal vein occlusion impacting central vision. This resource provides information on CRVO diagnosis, clinical documentation for accurate medical coding, and healthcare management. Find details on symptoms, treatment, and prognosis for retinal vein occlusion. Understand the importance of proper coding for CRVO in a healthcare setting.
Also known as
Other retinal vascular occlusions
Covers central retinal vein occlusion (CRVO).
Other retinal vascular occlusions
Includes unspecified retinal vein occlusion.
Disorders of retinal vessels
Encompasses various retinal vessel conditions, including occlusions.
Diseases of the eye and adnexa
Broad category for all eye-related disorders.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the central retinal vein occlusion unilateral or bilateral?
Unilateral
Is it specified as non-ischemic?
Bilateral
Is it specified as non-ischemic?
When to use each related code
| Description |
|---|
| Blockage of central retinal vein |
| Blockage of branch retinal vein |
| Ischemic central retinal vein occlusion |
Missing or incorrect laterality (right, left, bilateral) for CRVO impacts reimbursement and data accuracy. CDI can query for laterality documentation.
Distinguishing between ischemic and non-ischemic CRVO is crucial for accurate coding (H34.81 vs. H34.83) and affects severity reflection.
Coding for coexisting conditions like glaucoma or hypertension with CRVO is essential for accurate risk adjustment and treatment planning. CDI can clarify documentation.
Q: What are the key differentiating factors in diagnosing central retinal vein occlusion (CRVO) vs. branch retinal vein occlusion (BRVO) in clinical practice?
A: Differentiating between CRVO and BRVO hinges on the location and extent of retinal vein obstruction. CRVO involves the central retinal vein, resulting in widespread retinal hemorrhages and venous dilation throughout the retina, often described as 'blood and thunder' fundus appearance. BRVO, on the other hand, affects a branch of the retinal vein, leading to more localized retinal hemorrhage and edema confined to the affected quadrant or sector. Visual acuity in CRVO can range from near-normal to profound loss, while BRVO typically presents with milder visual impairment, correlating with the affected area. Consider implementing a thorough fundus examination, including fluorescein angiography if necessary, to confirm the diagnosis and assess the extent of vascular involvement. Explore how optical coherence tomography (OCT) can further aid in evaluating macular edema and guiding treatment decisions.
Q: How do I effectively manage a patient presenting with ischemic central retinal vein occlusion (CRVO) and neovascularization?
A: Managing ischemic CRVO with neovascularization requires prompt and targeted intervention to prevent further vision loss. Ischemic CRVO is characterized by extensive capillary non-perfusion, often leading to neovascular glaucoma, a sight-threatening complication. Treatment focuses on inhibiting the growth of new, abnormal blood vessels (neovascularization) which can cause vitreous hemorrhage, retinal detachment, and elevated intraocular pressure. Anti-VEGF therapy is the cornerstone of management, aiming to reduce vascular endothelial growth factor (VEGF) levels that drive neovascularization. Learn more about the various anti-VEGF agents available and their specific dosing regimens. Additionally, consider implementing panretinal photocoagulation (PRP) to reduce ischemic retinal areas and the production of VEGF. Close monitoring of intraocular pressure and regular follow-up examinations are crucial for optimal management and timely intervention in cases of neovascular glaucoma development.
Patient presents with symptoms suggestive of Central Retinal Vein Occlusion (CRVO). Presenting complaint includes sudden painless vision loss or blurred vision in the affected eye. Examination reveals retinal hemorrhages, dilated and tortuous retinal veins, and optic disc edema. Macular edema may be present, contributing to decreased visual acuity. Differential diagnosis includes branch retinal vein occlusion (BRVO), ocular ischemic syndrome, and diabetic retinopathy. Fluorescein angiography (FA) may be performed to confirm the diagnosis of CRVO and assess macular perfusion. Optical coherence tomography (OCT) is utilized to evaluate the presence and extent of macular edema. The patient's medical history was reviewed for risk factors such as hypertension, diabetes mellitus, hyperlipidemia, glaucoma, and cardiovascular disease. Initial treatment plan includes close observation and management of underlying systemic conditions. Intravitreal injections of anti-VEGF agents may be considered for macular edema to improve visual acuity. Patient education regarding the condition, potential complications including neovascular glaucoma, and the importance of follow-up care was provided. The patient will be scheduled for regular ophthalmologic examinations to monitor disease progression and response to treatment. ICD-10 code H34.81, Central retinal vein occlusion, is recorded for this encounter.